At the heart of BZETH Pharmaceuticals are its founders, Dr Vaishali Rawal and Dr Chandramauli Rawal whose shared vision, scientific expertise, and deep commitment to patient care have shaped the company from the ground up. With a combined background in medicine, pharmaceutical sciences, biotechnology, and clinical research, they founded BZETH Pharmaceuticals with a mission to provide high-quality, life-changing digestive enzyme therapies for individuals affected by enzyme deficiencies such as exocrine pancreatic insufficiency (EPI), cystic fibrosis, and related gastrointestinal disorders. Driven by a belief that science should serve people, they bring decades of hands-on experience in drug development, regulatory affairs, and biomanufacturing. Their leadership continues to inspire innovation, integrity, and excellence across every aspect of the organization—from R&D to production to patient support. Together, they are building more than just a company—they are building a legacy of care, rooted in purpose and progress.
Reach out to us and our team will get back to you shortly.